APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical Excipients for Oral Solid Dosage Forms

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Pharmaceutical Excipients for Oral Solid Dosage Forms Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

23 December 2025199 pages

Choose your research edition.

Industry ResearchPharmaceutical Excipients for Oral Solid Dosage Forms Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical Excipients for Oral Solid Dosage Forms Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Pharmaceutical Excipients for Oral Solid Dosage Forms Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical Excipients for Oral Solid Dosage Forms Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical Excipients for Oral Solid Dosage Forms Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Pharmaceutical Excipients for Oral Solid Dosage Forms market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Pharmaceutical Excipients for Oral Solid Dosage Forms is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pharmaceutical Excipients for Oral Solid Dosage Forms is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmaceutical Excipients for Oral Solid Dosage Forms is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pharmaceutical Excipients for Oral Solid Dosage Forms is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pharmaceutical Excipients for Oral Solid Dosage Forms include Ashland, Associated British Foods, BASF, Croda International, Dow, Evonik, JRS Pharma, Lubrizol and Mitsubishi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pharmaceutical Excipients for Oral Solid Dosage Forms market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharmaceutical Excipients for Oral Solid Dosage Forms and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharmaceutical Excipients for Oral Solid Dosage Forms sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pharmaceutical Excipients for Oral Solid Dosage Forms market size, projected growth trends, production technologies, key applications, and end-use industries.

Pharmaceutical Excipients for Oral Solid Dosage Forms Segment by Company

Ashland

Associated British Foods

BASF

Croda International

Dow

Evonik

JRS Pharma

Lubrizol

Mitsubishi

Roquette

Shin-Etsu

Südzucker AG

Hunan Er-Kang Pharmaceutical Co., Ltd.

Tianjin Chasesun Pharmaceutical Co., Ltd.

Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.

Sunrise Manufacture Group Co., Ltd.

Nanjing Well Pharmaceutical Group Co.,Ltd.

Xiwang Group

Pharmaceutical Excipients for Oral Solid Dosage Forms Segment by Type

Fillers

Lubricants

Binders

Disintegrants

Coating Materials

Other

Pharmaceutical Excipients for Oral Solid Dosage Forms Segment by Application

Tablets

Granules and Powders

Capsules

Pharmaceutical Excipients for Oral Solid Dosage Forms Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Excipients for Oral Solid Dosage Forms market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Excipients for Oral Solid Dosage Forms and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Excipients for Oral Solid Dosage Forms.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pharmaceutical Excipients for Oral Solid Dosage Forms market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pharmaceutical Excipients for Oral Solid Dosage Forms manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Pharmaceutical Excipients for Oral Solid Dosage Forms in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Pharmaceutical Excipients for Oral Solid Dosage Forms in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Pharmaceutical Excipients for Oral Solid Dosage Forms Industry Trends Table 2. Pharmaceutical Excipients for Oral Solid Dosage Forms Industry Drivers Table 3. Pharmaceutical Excipients for Oral Solid Dosage Forms Industry Opportunities and Challenges Table 4. Pharmaceutical Excipients for Oral Solid Dosage Forms Industry Restraints Table 5. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Manufacturers (t) & (2021-2026) Table 8. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share by Manufacturers Table 9. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Average Sales Price (USD/t) of Manufacturers (2021-2026) Table 10. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Manufacturers, Product Type & Application Table 13. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Pharmaceutical Excipients for Oral Solid Dosage Forms by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Fillers Table 17. Major Manufacturers of Lubricants Table 18. Major Manufacturers of Binders Table 19. Major Manufacturers of Disintegrants Table 20. Major Manufacturers of Coating Materials Table 21. Major Manufacturers of Other Table 22. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Type 2021 VS 2025 VS 2032 (t) Table 23. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Type (2021-2026) & (t) Table 24. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Type (2027-2032) & (t) Table 25. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share by Type (2021-2026) Table 26. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share by Type (2027-2032) Table 27. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Type 2021 VS 2025 VS 2032 (t) Table 28. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Type (2021-2026) & (t) Table 29. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Type (2027-2032) & (t) Table 30. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Market Share by Type (2021-2026) Table 31. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Market Share by Type (2027-2032) Table 32. Major Manufacturers of Tablets Table 33. Major Manufacturers of Granules and Powders Table 34. Major Manufacturers of Capsules Table 35. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Application 2021 VS 2025 VS 2032 (t) Table 36. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Application (2021-2026) & (t) Table 37. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Application (2027-2032) & (t) Table 38. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share by Application (2021-2026) Table 39. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share by Application (2027-2032) Table 40. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Application 2021 VS 2025 VS 2032 (t) Table 41. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Application (2021-2026) & (t) Table 42. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Application (2027-2032) & (t) Table 43. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Market Share by Application (2021-2026) Table 44. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Market Share by Application (2027-2032) Table 45. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Region: 2021 VS 2025 VS 2032 (t) Table 46. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Region (2021-2026) & (t) Table 47. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share by Region (2021-2026) Table 48. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Forecasted by Region (2027-2032) & (t) Table 49. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Forecasted Market Share by Region (2027-2032) Table 50. North America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (t) Table 51. North America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Country (2021-2026) & (t) Table 52. North America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Country (2027-2032) & (t) Table 53. Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (t) Table 54. Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Country (2021-2026) & (t) Table 55. Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Country (2027-2032) & (t) Table 56. Asia Pacific Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (t) Table 57. Asia Pacific Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Country (2021-2026) & (t) Table 58. Asia Pacific Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Country (2027-2032) & (t) Table 59. South America, Middle East and Africa Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (t) Table 60. South America, Middle East and Africa Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Country (2021-2026) & (t) Table 61. South America, Middle East and Africa Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Country (2027-2032) & (t) Table 62. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Region (2021-2026) & (US$ Million) Table 64. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Region (2027-2032) & (US$ Million) Table 65. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Market Share by Region (2021-2026) Table 66. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Market Share by Region (2027-2032) Table 67. Ashland Company Information Table 68. Ashland Business Overview Table 69. Ashland Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Ashland Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 71. Ashland Recent Development Table 72. Associated British Foods Company Information Table 73. Associated British Foods Business Overview Table 74. Associated British Foods Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Associated British Foods Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 76. Associated British Foods Recent Development Table 77. BASF Company Information Table 78. BASF Business Overview Table 79. BASF Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. BASF Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 81. BASF Recent Development Table 82. Croda International Company Information Table 83. Croda International Business Overview Table 84. Croda International Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Croda International Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 86. Croda International Recent Development Table 87. Dow Company Information Table 88. Dow Business Overview Table 89. Dow Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Dow Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 91. Dow Recent Development Table 92. Evonik Company Information Table 93. Evonik Business Overview Table 94. Evonik Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Evonik Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 96. Evonik Recent Development Table 97. JRS Pharma Company Information Table 98. JRS Pharma Business Overview Table 99. JRS Pharma Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. JRS Pharma Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 101. JRS Pharma Recent Development Table 102. Lubrizol Company Information Table 103. Lubrizol Business Overview Table 104. Lubrizol Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Lubrizol Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 106. Lubrizol Recent Development Table 107. Mitsubishi Company Information Table 108. Mitsubishi Business Overview Table 109. Mitsubishi Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Mitsubishi Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 111. Mitsubishi Recent Development Table 112. Roquette Company Information Table 113. Roquette Business Overview Table 114. Roquette Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Roquette Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 116. Roquette Recent Development Table 117. Shin-Etsu Company Information Table 118. Shin-Etsu Business Overview Table 119. Shin-Etsu Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Shin-Etsu Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 121. Shin-Etsu Recent Development Table 122. Südzucker AG Company Information Table 123. Südzucker AG Business Overview Table 124. Südzucker AG Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. Südzucker AG Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 126. Südzucker AG Recent Development Table 127. Hunan Er-Kang Pharmaceutical Co., Ltd. Company Information Table 128. Hunan Er-Kang Pharmaceutical Co., Ltd. Business Overview Table 129. Hunan Er-Kang Pharmaceutical Co., Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. Hunan Er-Kang Pharmaceutical Co., Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 131. Hunan Er-Kang Pharmaceutical Co., Ltd. Recent Development Table 132. Tianjin Chasesun Pharmaceutical Co., Ltd. Company Information Table 133. Tianjin Chasesun Pharmaceutical Co., Ltd. Business Overview Table 134. Tianjin Chasesun Pharmaceutical Co., Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 135. Tianjin Chasesun Pharmaceutical Co., Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 136. Tianjin Chasesun Pharmaceutical Co., Ltd. Recent Development Table 137. Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Company Information Table 138. Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Business Overview Table 139. Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 140. Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 141. Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Recent Development Table 142. Sunrise Manufacture Group Co., Ltd. Company Information Table 143. Sunrise Manufacture Group Co., Ltd. Business Overview Table 144. Sunrise Manufacture Group Co., Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 145. Sunrise Manufacture Group Co., Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 146. Sunrise Manufacture Group Co., Ltd. Recent Development Table 147. Nanjing Well Pharmaceutical Group Co.,Ltd. Company Information Table 148. Nanjing Well Pharmaceutical Group Co.,Ltd. Business Overview Table 149. Nanjing Well Pharmaceutical Group Co.,Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 150. Nanjing Well Pharmaceutical Group Co.,Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 151. Nanjing Well Pharmaceutical Group Co.,Ltd. Recent Development Table 152. Xiwang Group Company Information Table 153. Xiwang Group Business Overview Table 154. Xiwang Group Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 155. Xiwang Group Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 156. Xiwang Group Recent Development Table 157. Key Raw Materials Table 158. Raw Materials Key Suppliers Table 159. Pharmaceutical Excipients for Oral Solid Dosage Forms Distributors List Table 160. Pharmaceutical Excipients for Oral Solid Dosage Forms Customers List Table 161. Research Programs/Design for This Report Table 162. Authors List of This Report Table 163. Secondary Sources Table 164. Primary Sources List of Figures Figure 1. Pharmaceutical Excipients for Oral Solid Dosage Forms Product Image Figure 2. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size (2021-2032) & (US$ Million) Figure 4. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (2021-2032) & (t) Figure 5. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Average Price (USD/t) & (2021-2032) Figure 6. Global Top 5 and 10 Pharmaceutical Excipients for Oral Solid Dosage Forms Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Fillers Image Figure 9. Lubricants Image Figure 10. Binders Image Figure 11. Disintegrants Image Figure 12. Coating Materials Image Figure 13. Other Image Figure 14. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Type (2021 VS 2025 VS 2032) & (t) Figure 15. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share 2021 VS 2025 VS 2032 Figure 16. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share by Type (2021-2032) Figure 17. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Type (2021 VS 2025 VS 2032) & (t) Figure 18. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Market Share by Type (2021-2032) Figure 20. Tablets Image Figure 21. Granules and Powders Image Figure 22. Capsules Image Figure 23. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Application (2021 VS 2025 VS 2032) & (t) Figure 24. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share 2021 VS 2025 VS 2032 Figure 25. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share by Application (2021-2032) Figure 26. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Application (2021 VS 2025 VS 2032) & (t) Figure 27. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Market Share 2021 VS 2025 VS 2032 Figure 28. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Market Share by Application (2021-2032) Figure 29. North America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales and Growth Rate (2021-2032) & (t) Figure 30. North America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share by Country (2021-2032) Figure 31. U.S. Pharmaceutical Excipients for Oral Solid Dosage Forms Sales and Growth Rate (2021-2032) & (t) Figure 32. Canada Pharmaceutical Excipients for Oral Solid Dosage Forms Sales and Growth Rate (2021-2032) & (t) Figure 33. Mexico Pharmaceutical Excipients for Oral Solid Dosage Forms Sales and Growth Rate (2021-2032) & (t) Figure 34. Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Sales and Growth Rate (2021-2032) & (t) Figure 35. Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share by Country (2021-2032) Figure 36. Germany Pharmaceutical Excipients for Oral Solid Dosage Forms Sales and Growth Rate (2021-2032) & (t) Figure 37. France Pharmaceutical Excipients for Oral Solid Dosage Forms Sales and Growth Rate (2021-2032) & (t) Figure 38. U.K. Pharmaceutical Excipients for Oral Solid Dosage Forms Sales and Growth Rate (2021-2032) & (t) Figure 39. Italy Pharmaceutical Excipients for Oral Solid Dosage Forms Sales and Growth Rate (2021-2032) & (t) Figure 40. Netherlands Pharmaceutical Excipients for Oral Solid Dosage Forms Sales and Growth Rate (2021-2032) & (t) Figure 41. Asia Pacific Pharmaceutical Excipients for Oral Solid Dosage Forms Sales and Growth Rate (2021-2032) & (t) Figure 42. Asia Pacific Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share by Country (2021-2032) Figure 43. China Pharmaceutical Excipients for Oral Solid Dosage Forms Sales and Growth Rate (2021-2032) & (t) Figure 44. Japan Pharmaceutical Excipients for Oral Solid Dosage Forms Sales and Growth Rate (2021-2032) & (t) Figure 45. South Korea Pharmaceutical Excipients for Oral Solid Dosage Forms Sales and Growth Rate (2021-2032) & (t) Figure 46. Southeast Asia Pharmaceutical Excipients for Oral Solid Dosage Forms Sales and Growth Rate (2021-2032) & (t) Figure 47. India Pharmaceutical Excipients for Oral Solid Dosage Forms Sales and Growth Rate (2021-2032) & (t) Figure 48. Australia Pharmaceutical Excipients for Oral Solid Dosage Forms Sales and Growth Rate (2021-2032) & (t) Figure 49. South America, Middle East and Africa Pharmaceutical Excipients for Oral Solid Dosage Forms Sales and Growth Rate (2021-2032) & (t) Figure 50. South America, Middle East and Africa Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share by Country (2021-2032) Figure 51. Brazil Pharmaceutical Excipients for Oral Solid Dosage Forms Sales and Growth Rate (2021-2032) & (t) Figure 52. South Africa Pharmaceutical Excipients for Oral Solid Dosage Forms Sales and Growth Rate (2021-2032) & (t) Figure 53. Saudi Arabia Pharmaceutical Excipients for Oral Solid Dosage Forms Sales and Growth Rate (2021-2032) & (t) Figure 54. Turkey Pharmaceutical Excipients for Oral Solid Dosage Forms Sales and Growth Rate (2021-2032) & (t) Figure 55. Argentina Pharmaceutical Excipients for Oral Solid Dosage Forms Sales and Growth Rate (2021-2032) & (t) Figure 56. UAE Pharmaceutical Excipients for Oral Solid Dosage Forms Sales and Growth Rate (2021-2032) & (t) Figure 57. Egypt Pharmaceutical Excipients for Oral Solid Dosage Forms Sales and Growth Rate (2021-2032) & (t) Figure 58. Chile Pharmaceutical Excipients for Oral Solid Dosage Forms Sales and Growth Rate (2021-2032) & (t) Figure 59. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 61. North America Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue (2021-2032) & (US$ Million) Figure 62. North America Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue (2021-2032) & (US$ Million) Figure 64. Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue (2021-2032) & (US$ Million) Figure 66. Asia-Pacific Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. South America, Middle East and Africa Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue (2021-2032) & (US$ Million) Figure 68. South America, Middle East and Africa Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. Pharmaceutical Excipients for Oral Solid Dosage Forms Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Pharmaceutical Excipients for Oral Solid Dosage Forms Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Fillers
  • Lubricants
  • Binders
  • Disintegrants
  • Coating Materials
  • Other
Applications
  • Tablets
  • Granules and Powders
  • Capsules
Companies covered
  • Ashland
  • Associated British Foods
  • BASF
  • Croda International
  • Dow
  • Evonik
  • JRS Pharma
  • Lubrizol
  • Mitsubishi
  • Roquette
  • Shin-Etsu
  • Südzucker AG
  • Hunan Er-Kang Pharmaceutical Co., Ltd.
  • Tianjin Chasesun Pharmaceutical Co., Ltd.
  • Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.
  • Sunrise Manufacture Group Co., Ltd.
  • Nanjing Well Pharmaceutical Group Co.,Ltd.
  • Xiwang Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Market Dynamics
  1. 2.1 Pharmaceutical Excipients for Oral Solid Dosage Forms Industry Trends
  2. 2.2 Pharmaceutical Excipients for Oral Solid Dosage Forms Industry Drivers
  3. 2.3 Pharmaceutical Excipients for Oral Solid Dosage Forms Industry Opportunities and Challenges
  4. 2.4 Pharmaceutical Excipients for Oral Solid Dosage Forms Industry Restraints
3 Pharmaceutical Excipients for Oral Solid Dosage Forms Market by Manufacturers
  1. 3.1 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Manufacturers (2021-2026)
  3. 3.3 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Manufacturers, Product Type & Application
  7. 3.7 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pharmaceutical Excipients for Oral Solid Dosage Forms Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pharmaceutical Excipients for Oral Solid Dosage Forms Tier 1, Tier 2, and Tier 3
4 Pharmaceutical Excipients for Oral Solid Dosage Forms Market by Type
  1. 4.1 Pharmaceutical Excipients for Oral Solid Dosage Forms Type Introduction
  2. 4.1.1 Fillers
  3. 4.1.2 Lubricants
  4. 4.1.3 Binders
  5. 4.1.4 Disintegrants
  6. 4.1.5 Coating Materials
  7. 4.1.6 Other
  8. 4.2 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Type
  9. 4.2.1 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Type (2021-2032)
  11. 4.2.3 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share by Type (2021-2032)
  12. 4.3 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Type
  13. 4.3.1 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Type (2021-2032)
  15. 4.3.3 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Market Share by Type (2021-2032)
5 Pharmaceutical Excipients for Oral Solid Dosage Forms Market by Application
  1. 5.1 Pharmaceutical Excipients for Oral Solid Dosage Forms Application Introduction
  2. 5.1.1 Tablets
  3. 5.1.2 Granules and Powders
  4. 5.1.3 Capsules
  5. 5.2 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Application
  6. 5.2.1 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Application (2021-2032)
  8. 5.2.3 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share by Application (2021-2032)
  9. 5.3 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Application
  10. 5.3.1 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Application (2021-2032)
  12. 5.3.3 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Market Share by Application (2021-2032)
6 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Region
  1. 6.1 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Region (2021-2032)
  3. 6.2.1 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Region (2021-2026)
  4. 6.2.2 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Region
  1. 7.1 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Region
  2. 7.1.1 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Region (2021-2026)
  4. 7.1.3 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue by Region (2027-2032)
  5. 7.1.4 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue (2021-2032)
  8. 7.2.2 North America Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue (2021-2032)
  11. 7.3.2 Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Ashland
  2. 8.1.1 Ashland Company Information
  3. 8.1.2 Ashland Business Overview
  4. 8.1.3 Ashland Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Ashland Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  6. 8.1.5 Ashland Recent Developments
  7. 8.2 Associated British Foods
  8. 8.2.1 Associated British Foods Company Information
  9. 8.2.2 Associated British Foods Business Overview
  10. 8.2.3 Associated British Foods Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Associated British Foods Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  12. 8.2.5 Associated British Foods Recent Developments
  13. 8.3 BASF
  14. 8.3.1 BASF Company Information
  15. 8.3.2 BASF Business Overview
  16. 8.3.3 BASF Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 BASF Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  18. 8.3.5 BASF Recent Developments
  19. 8.4 Croda International
  20. 8.4.1 Croda International Company Information
  21. 8.4.2 Croda International Business Overview
  22. 8.4.3 Croda International Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Croda International Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  24. 8.4.5 Croda International Recent Developments
  25. 8.5 Dow
  26. 8.5.1 Dow Company Information
  27. 8.5.2 Dow Business Overview
  28. 8.5.3 Dow Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Dow Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  30. 8.5.5 Dow Recent Developments
  31. 8.6 Evonik
  32. 8.6.1 Evonik Company Information
  33. 8.6.2 Evonik Business Overview
  34. 8.6.3 Evonik Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Evonik Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  36. 8.6.5 Evonik Recent Developments
  37. 8.7 JRS Pharma
  38. 8.7.1 JRS Pharma Company Information
  39. 8.7.2 JRS Pharma Business Overview
  40. 8.7.3 JRS Pharma Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 JRS Pharma Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  42. 8.7.5 JRS Pharma Recent Developments
  43. 8.8 Lubrizol
  44. 8.8.1 Lubrizol Company Information
  45. 8.8.2 Lubrizol Business Overview
  46. 8.8.3 Lubrizol Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Lubrizol Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  48. 8.8.5 Lubrizol Recent Developments
  49. 8.9 Mitsubishi
  50. 8.9.1 Mitsubishi Company Information
  51. 8.9.2 Mitsubishi Business Overview
  52. 8.9.3 Mitsubishi Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Mitsubishi Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  54. 8.9.5 Mitsubishi Recent Developments
  55. 8.10 Roquette
  56. 8.10.1 Roquette Company Information
  57. 8.10.2 Roquette Business Overview
  58. 8.10.3 Roquette Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Roquette Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  60. 8.10.5 Roquette Recent Developments
  61. 8.11 Shin-Etsu
  62. 8.11.1 Shin-Etsu Company Information
  63. 8.11.2 Shin-Etsu Business Overview
  64. 8.11.3 Shin-Etsu Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Shin-Etsu Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  66. 8.11.5 Shin-Etsu Recent Developments
  67. 8.12 Südzucker AG
  68. 8.12.1 Südzucker AG Company Information
  69. 8.12.2 Südzucker AG Business Overview
  70. 8.12.3 Südzucker AG Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Südzucker AG Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  72. 8.12.5 Südzucker AG Recent Developments
  73. 8.13 Hunan Er-Kang Pharmaceutical Co., Ltd.
  74. 8.13.1 Hunan Er-Kang Pharmaceutical Co., Ltd. Company Information
  75. 8.13.2 Hunan Er-Kang Pharmaceutical Co., Ltd. Business Overview
  76. 8.13.3 Hunan Er-Kang Pharmaceutical Co., Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Hunan Er-Kang Pharmaceutical Co., Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  78. 8.13.5 Hunan Er-Kang Pharmaceutical Co., Ltd. Recent Developments
  79. 8.14 Tianjin Chasesun Pharmaceutical Co., Ltd.
  80. 8.14.1 Tianjin Chasesun Pharmaceutical Co., Ltd. Company Information
  81. 8.14.2 Tianjin Chasesun Pharmaceutical Co., Ltd. Business Overview
  82. 8.14.3 Tianjin Chasesun Pharmaceutical Co., Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Tianjin Chasesun Pharmaceutical Co., Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  84. 8.14.5 Tianjin Chasesun Pharmaceutical Co., Ltd. Recent Developments
  85. 8.15 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.
  86. 8.15.1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Company Information
  87. 8.15.2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Business Overview
  88. 8.15.3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  90. 8.15.5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Recent Developments
  91. 8.16 Sunrise Manufacture Group Co., Ltd.
  92. 8.16.1 Sunrise Manufacture Group Co., Ltd. Company Information
  93. 8.16.2 Sunrise Manufacture Group Co., Ltd. Business Overview
  94. 8.16.3 Sunrise Manufacture Group Co., Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Sunrise Manufacture Group Co., Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  96. 8.16.5 Sunrise Manufacture Group Co., Ltd. Recent Developments
  97. 8.17 Nanjing Well Pharmaceutical Group Co.,Ltd.
  98. 8.17.1 Nanjing Well Pharmaceutical Group Co.,Ltd. Company Information
  99. 8.17.2 Nanjing Well Pharmaceutical Group Co.,Ltd. Business Overview
  100. 8.17.3 Nanjing Well Pharmaceutical Group Co.,Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Nanjing Well Pharmaceutical Group Co.,Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  102. 8.17.5 Nanjing Well Pharmaceutical Group Co.,Ltd. Recent Developments
  103. 8.18 Xiwang Group
  104. 8.18.1 Xiwang Group Company Information
  105. 8.18.2 Xiwang Group Business Overview
  106. 8.18.3 Xiwang Group Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Xiwang Group Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  108. 8.18.5 Xiwang Group Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pharmaceutical Excipients for Oral Solid Dosage Forms Value Chain Analysis
  2. 9.1.1 Pharmaceutical Excipients for Oral Solid Dosage Forms Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pharmaceutical Excipients for Oral Solid Dosage Forms Production Mode & Process
  6. 9.2 Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pharmaceutical Excipients for Oral Solid Dosage Forms Distributors
  9. 9.2.3 Pharmaceutical Excipients for Oral Solid Dosage Forms Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst